Skip to main content

Table 6 Direct cost (test and treatment cost) and comprehensive cost (including estimate of life value) of the presumptive versus the test based strategy at "ideal" adherence levels to both strategies: test and treatment cost subsidized (see text)

From: Strict adherence to malaria rapid test results might lead to a neglect of other dangerous diseases: a cost benefit analysis from Burkina Faso

Variables

Children, dry season

Children, rainy season

Adults, dry season

Adults, rainy season

Direct cost, presumptive strategy

264

257

608

608

Direct cost, test-based strategy

209

247

485

516

Comprehensive cost, presumptive strategy

978

596

1330

1164

Comprehensive cost, test-based strategy

828

697

782

752

Threshold life value*

n.a. (pres. dominated)

44

n.a. (pres. dominated)

n.a. (pres. dominated)

  1. Costs expressed in € (euro) for 1000 patients managed with either strategy, assuming a life value of 525 € (better option in bold)
  2. * Life value at which the two strategies become equivalent at sensitivity analysis